Hanshang Group to set foot in health field by acquisition of Dikang Pharmaceutical

Summary: Hanshang Group and its subsidiary, Hanshang Health proposed to acquire Dikang Pharmaceutical's 100% shares with USD132.75 million (RMB900 million). After the acquisition, Dikang Pharmaceutical will become Hanshang Group's wholly-owned subsid...

Vitamins China E-News 202010

www.cnchemicals.com